{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:14:47Z","timestamp":1781190887493,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.regg.2026.101789","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:43:05Z","timestamp":1780065785000},"page":"101789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of pharmacological treatment in the secondary prevention of fragility fractures: A region-wide study"],"prefix":"10.1016","volume":"61","author":[{"given":"I\u00f1igo","family":"Etxebarria-Foronda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Ibarrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibai","family":"Herreros-Ugarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jokin","family":"Mart\u00ednez-Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaione","family":"Saez de Ugarte-Sobr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regg.2026.101789_bib0205","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","article-title":"Global, regional, national burden of bone fractures in 204 countries, territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.regg.2026.101789_bib0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.regg.2026.101789_bib0215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00198-019-04852-8","article-title":"Risk of imminent fracture following a previous fracture in a Swedish database study","volume":"30","author":"Banefelt","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0220","first-page":"373","article-title":"SECOT-GEIOS guidelines in osteoporosis and fragility fracture. An update","volume":"59","author":"Etxebarria-Foronda","year":"2015","journal-title":"Rev Esp Cir Ortop Traumatol"},{"key":"10.1016\/j.regg.2026.101789_bib0225","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","article-title":"Imminent risk of fracture after fracture","volume":"28","author":"Johansson","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0230","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","article-title":"Characteristics of recurrent fractures","volume":"29","author":"Kanis","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0235","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-006-0125-y","article-title":"Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study","volume":"17","author":"Nymark","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.3877","article-title":"Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition","volume":"35","author":"Conley","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.regg.2026.101789_bib0245","first-page":"461","article-title":"Prevalence and cost of subsequent fractures among U.S. patients with an incident fracture","volume":"23","author":"Weaver","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.regg.2026.101789_bib0250","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"5","author":"Wells","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.regg.2026.101789_bib0255","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.regg.2026.101789_bib0260","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.regg.2026.101789_bib0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0270","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifeneresults from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.regg.2026.101789_bib0275","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regg.2026.101789_bib0280","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regg.2026.101789_bib0285","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.regg.2026.101789_bib0290","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/jgs.14840","article-title":"Ageism in studies on the management of osteoporosis","volume":"65","author":"McGarvey","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.regg.2026.101789_bib0295","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1056\/NEJMp2407586","article-title":"\u201cTarget trial emulation\u201d for observational studies \u2013 potential and pitfalls","volume":"391","author":"Hubbard","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regg.2026.101789_bib0300","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00198-017-4175-0","article-title":"Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis","volume":"28","author":"Saito","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0305","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00198-015-3148-4","article-title":"Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials","volume":"26","author":"Chen","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0310","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.regg.2026.101789_bib0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40273-023-01326-y","article-title":"Cost-effectiveness analysis of vaccines for COVID-19 according to sex comorbidity and socioeconomic status: a population study","volume":"42","author":"Mar","year":"2024","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.regg.2026.101789_bib0320","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report","volume":"10","author":"Garrison","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.regg.2026.101789_bib0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/pan\/mpr025","article-title":"Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies","volume":"20","author":"Hainmueller","year":"2012","journal-title":"Polit Anal"},{"key":"10.1016\/j.regg.2026.101789_bib0330","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jval.2024.10.3855","article-title":"The excess direct social costs of dementia-related neuropsychiatric symptoms: a regionwide cohort study beyond silos","volume":"28","author":"Zumeta-Olaskoaga","year":"2025","journal-title":"Value Health"},{"key":"10.1016\/j.regg.2026.101789_bib0335","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jgs.14668","article-title":"Osteoporosis treatment efficacy for men: a systematic review and meta-analysis","volume":"65","author":"Nayak","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.regg.2026.101789_bib0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2407031","article-title":"Fracture prevention with infrequent zoledronate in women 50 to 60 years of age","volume":"392","author":"Bolland","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regg.2026.101789_bib0345","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10789","article-title":"Real-world effectiveness of osteoporosis medications in france: a nationwide cohort study","volume":"7","author":"Bosco-L\u00e9vy","year":"2023","journal-title":"JBMR Plus"},{"key":"10.1016\/j.regg.2026.101789_bib0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18168780","article-title":"Bisphosphonate use and hospitalization for hip fractures in women: an observational population-based study in France","volume":"18","author":"Bourrion","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.regg.2026.101789_bib0355","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00774-023-01411-4","article-title":"Association between pharmacotherapy and secondary hip fracture in a real-world setting: a nationwide database study","volume":"41","author":"Nakatoh","year":"2023","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.regg.2026.101789_bib0360","series-title":"Registro Nacional de Fracturas de Cadera. Informe Anual 2021","author":"S\u00e1ez L\u00f3pez","year":"2023"},{"key":"10.1016\/j.regg.2026.101789_bib0365","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.regg.2018.11.007","article-title":"Efficacy, cost, and aspects to take into account in the treatment of osteoporosis in the elderly","volume":"54","author":"S\u00e1ez-L\u00f3pez","year":"2019","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.regg.2026.101789_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.regg.2024.101582","article-title":"Efficacy and safety of osteoporosis treatment in older adults approach for the secondary prevention of fractures in older populations. A proposal by SEFRAOS","volume":"60","author":"Cuadra-Llopart","year":"2025","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.regg.2026.101789_bib0375","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00198-025-07564-4","article-title":"Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain","volume":"36","author":"Llopis-Cardona","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0380","article-title":"Rates of osteoporosis management and secondary preventative treatment after primary fragility fractures","volume":"6","author":"Ross","year":"2021","journal-title":"JB JS Open Access"},{"key":"10.1016\/j.regg.2026.101789_bib0385","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.165.8.905","article-title":"Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients","volume":"165","author":"Majumdar","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.regg.2026.101789_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2018.09.020","article-title":"Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: a systematic review and meta-analysis","volume":"120","author":"D\u00edez-P\u00e9rez","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.regg.2026.101789_bib0395","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00198-019-05255-5","article-title":"A fall in the previous 12 months predicts fracture in the subsequent 5 years in postmenopausal women","volume":"31","author":"Afrin","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.regg.2026.101789_bib0400","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/CEOR.S480674","article-title":"Actions to improve the secondary prevention of fragility fractures in women with postmenopausal osteoporosis: a social return on investment (SROI) study","volume":"16","author":"Olmo-Montes","year":"2024","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X2600048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X2600048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:46:12Z","timestamp":1781189172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211139X2600048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0211139X2600048X"],"URL":"https:\/\/doi.org\/10.1016\/j.regg.2026.101789","relation":{},"ISSN":["0211-139X"],"issn-type":[{"value":"0211-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of pharmacological treatment in the secondary prevention of fragility fractures: A region-wide study","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regg.2026.101789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SEGG. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101789"}}